|
2015 |
Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2015 |
CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. |
|
|
2015 |
Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors. |
Frank Porreca, PhD |
|
2015 |
Use of Animal Models in Understanding Cancer-induced Bone Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2015 |
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor. |
Patrick W Mantyh |
|
2015 |
Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. |
John M. Streicher, PhD |
|
2016 |
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain. |
Tally Largent-Milnes, PhD, Patrick W Mantyh, Todd Vanderah, PhD |
|
2016 |
Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment. |
|
|
2016 |
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2016 |
Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling. |
Nam Lee, Ph.D. |
|
2016 |
Neuroendocrinology: Oestrogen therapy affects brain structure but not function. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. |
Frank Porreca, PhD |
|
2016 |
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion. |
John M. Streicher, PhD |
|
2016 |
Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery. |
Jeffrey J. Lochhead, PhD |
|
2016 |
Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Dynorphin A analogs for the treatment of chronic neuropathic pain. |
|
|
2016 |
Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Cyclic non-opioid dynorphin A analogues for the bradykinin receptors. |
Frank Porreca, PhD |
|
2016 |
Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
|
2016 |
(S)-Lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2016 |
Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex. |
Roberta Diaz Brinton, Ph.D |
